Key result
Hyperionic profile haemodialysis reduces vasoactive hormones and prevents intracellular volume shifts vs conventional bicarbonate dialysis.
Why the study?
Does profile haemodialysis improve body fluid distribution and reduce the release of vasoactive hormones compared to conventional haemodialysis in elderly patients with end-stage renal failure and coronary heart disease?
Does profile haemodialysis improve body fluid distribution and reduce the release of vasoactive hormones compared to conventional haemodialysis in elderly patients with end-stage renal failure and coronary heart disease?
In elderly patients with end-stage renal failure and coronary heart disease, hyperionic profile haemodialysis reduces the release of vasoactive hormones and prevents intracellular fluid shifts compared to conventional dialysis, suggesting less cardiovascular impact.
May lessen intradialytic stress in elderly ESRD; hypothesis-generating and requires randomized confirmation before practice change.
In 15 patients with end-stage renal failure and proven coronary heart disease, profile haemodialysis with decreasing ultrafiltration rate and hyperionic, decreasing dialysate solute concentration was compared with conventional, extracorporeal bicarbonate haemodialysis (Na+D = 138 mmol/l). Body fluid distribution and the release of vasoactive hormones (plasma renin activity, aldosterone, norepinephrine, epinephrine, and atrial natriuretic peptide) were investigated. Haemodialysis with constant ultrafiltration rate and constant dialysate composition (A) was followed by two dialysis profiles: decreasing ultrafiltration rate (B) and additional hyperionic, decreasing dialysate sodium concentration (C). In all 15 patients, the dialysis procedures (A) - (C) were used for 2 weeks each with six sessions, the last being taken for investigation. Body fluid distribution was calculated. In patients with serum sodium above 136 mmol/l, the conventional dialysis (A) as well as the Uf profile (B) showed a net fluid shift from extracellular volume (ECV) to intracellular volume (ICV). Using the profile with hyperionic, decreasing Na+D (C), the reverse fluid shift with decreasing ICV was achieved not only in those with serum Na+ <136 mmol/l, but also in those with serum Na+ > or = 136 mmol/l. The release of vasoactive hormones decreased already at profile haemodialysis (B) compared with (A) and was further reduced in (C). These results would suggest, profile dialyses B and C to have less impact on the cardiovascular system in elderly patients assuming higher patient comfort compared with the standard dialysis procedure. A higher benefit was obtained in C compared with B, presumably due to the additional prevention of the ICV shift and plasma volume depletion in patients with initial serum sodium > or = 136 mmol/l using transiently hyperionic Na+D. These results show that in elderly patients, hyperionic profile haemodialysis (Na+D > Na+S) had less impact on cardiovascular regulation than conventional bicarbonate dialysis.
No takes yet. Share an insight, caveat, or question.
Ebel et al. (2008) studied End-stage renal failure and coronary heart disease (n=15). Profile haemodialysis (decreasing ultrafiltration rate with or without hyperionic decreasing dialysate sodium) vs. Conventional bicarbonate haemodialysis was evaluated on Body fluid distribution and release of vasoactive hormones. Hyperionic profile haemodialysis reduced the release of vasoactive hormones and prevented intracellular volume shifts compared with conventional bicarbonate dialysis in elderly patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: